Sheller Tries To Stop FDA Bid To End Risperdal Doc Suit
Sheller PC hit back Monday in a fight with the Food and Drug Administration over the firm's standing to bring a citizen complaint aimed at forcing a Johnson & Johnson unit...To view the full article, register now.
Already a subscriber? Click here to view full article